Navigation Links
PharmaNet Development Group Symposia 'Crossing the Bridge from Preclinical to Clinical Studies' to be Held February 2010 in Basel, Dusseldorf and Vienna
Date:1/11/2010

PRINCETON, N.J., Jan. 11 /PRNewswire/ -- PharmaNet Development Group, Inc., a leading provider of clinical development services to innovative pharmaceutical, biotechnology, generic drug and medical device companies, is pleased to announce that it is hosting a complementary symposium and round table discussion entitled "Crossing the Bridge from Preclinical to Clinical Studies".

Recently, the Company successfully hosted a similar symposium in Sweden. Due to its success, the Company will be hosting the event in other important biotechnology centers in Europe. The symposia will be held in:

Basel, Switzerland on 9 February 2010

Dusseldorf, Germany on 10 February 2010

Vienna, Austria on 11 February 2010

Robert Reekie, Senior Executive Vice President, Europe and Asia-Pacific, said, "This symposium demonstrates PharmaNet's commitment to the European Biotech sector and the expertise that we can bring to clinical programs as we assist biopharmaceutical companies commercialise their products efficiently."

Whether facing complex regulatory requirements, conducting first-in-man studies, or developing clinical development plans for late stage clinical trials, PharmaNet senior-level professionals assist biopharmaceutical companies in navigating this critical stage of drug development. With established credentials, proven experience, and insight acquired through working with international regulatory agencies, PharmaNet provides viable strategies to conduct studies from Phase I through Phase IV utilizing its global network of resources.

For Phase I clinical development, the Company's clinics have more than 300 beds and access to numerous special populations. For Phase II-IV clinical development programs, PharmaNet conducts studies in virtually all therapeutic areas, including oncology, cardiology, dermatology, infectious diseases, neurosciences, ophthalmology, women's health, pediatrics, and Phase IV development.

Robert Reekie will chair the symposia. Other PharmaNet experts will discuss innovative approaches to concept testing and market authorization including the following topics:

  • New Scientific and Regulatory Approaches for Flexible Design of Early Stage Trials and Their Preclinical Support, Bengt R. Danielsson, MD, PhD, Vice President, PharmaNet Consulting
  • Overview on Global Approaches for Scientific Advice and Regulatory Submissions, Franz Buchholzer, PhD, Vice President, Worldwide Regulatory Operations
  • Strategies for Effective Drug Development, Gregory M Hockel, PhD, Executive Vice President, Worldwide Regulatory Operations
  • Designing Safe and Efficient Phase I Studies, Mario Tanquay, PhD, BPharmSc, Vice President, Scientific & Regulatory Affairs
  • Arriving to the Clinical Side: Trial Design Considerations, Jeff Freitag, MD, Senior Vice President, PharmaNet Consulting

To attend the conference, please contact Klaus Haller at +49 8989557755 or by email khaller@pharmanet.com.

About PharmaNet Development Group, Inc.

PharmaNet Development Group, Inc., a global drug development services company, provides a comprehensive range of services to the pharmaceutical, biotechnology, generic drug and medical device industries. The Company offers early and late stage consulting, Phase I clinical studies and bioanalytical analyses, and Phase II, III and IV clinical development programs. With approximately 2,300 employees and 43 facilities throughout the world, PharmaNet is a recognized leader in outsourced clinical development. For more information, please visit our website at www.pharmanet.com.


    Contact: Patricia Hall
    Phone: +44 1494 896202
    E-mail: phall@pharmanet.com

SOURCE PharmaNet Development Group, Inc.


'/>"/>
SOURCE PharmaNet Development Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Jeffrey Trotter Joins Pharmanet Development Group as Executive Vice President, Phase IV Development
2. PharmaNet Development Group Management Participates in the 8th Annual Partnerships in Clinical Trials Conference in Rotterdam
3. Azopharma and PharmaNet Development Group Enter Preclinical Strategic Alliance
4. PharmaNet Development Group To Showcase Innovative Solutions and Poster Presentations at AAPS 2009
5. Echo Therapeutics Announces Major Milestone: The Completion of Product Development Work of its Revolutionary, Patented Prelude(TM) SkinPrep System
6. WuXi AppTec and QIAGEN Enter into Partnership Agreement for Molecular Biomarker Development
7. Solos Endoscopy, Inc. Set to Increase Business Through Sales and Product Development in 2010
8. Lilly and Incyte Announce Collaboration for Development and Commercialization of Oral Anti-Inflammatory and Autoimmune Therapies
9. Karolinska Development New Share Issue Completed - Raising 380 MSEK (36 MEUR)
10. Vivakor Signs Business Development Agreement With Baker Consulting
11. EDP Biotech Takes Next Step in the Development of ColoMarker
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... -- AbbVie (NYSE: ABBV), a global biopharmaceutical company, today ... C virus (HCV) infected patients with genotype 1, ... (Child-Pugh A) achieved sustained virologic response at 12 ... pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high SVR ... of G/P treatment without ribavirin. Patients with specific ...
(Date:4/20/2017)... 2017 Research and Markets has announced ... Services Market Analysis By Service (Manufacturing, Research), By Country, (Brazil, ... 2025" report to their offering. ... The Latin American pharmaceutical contract manufacturing services ... Low drug registration cost in Latin American countries ...
(Date:4/19/2017)... , April 19, 2017  IRIDEX Corporation (Nasdaq: ... financial results for the first quarter 2017 after the ... Company,s management team will host a corresponding conference call ... Investors interested in listening to the conference ... domestic callers or (703) 326-3030 for international callers, using ...
Breaking Medicine Technology:
(Date:4/25/2017)... San Jose, CA (PRWEB) , ... April 25, ... ... in cross-screen access, support, and collaboration, announces Mirroring360 Pro . This new ... providing a comprehensive collaboration experience for education and business. , Mirroring360 Pro enables ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... CFOs and HR decision-makers are preparing for how his administration could impact the ... provide insight into what changes are most likely to make it through Congress. ...
(Date:4/25/2017)... Vegas, NV (PRWEB) , ... April 25, 2017 ... ... can now choose a modern procedure that achieves results in a fraction of ... in Las Vegas, NV, with Significance Dental Specialists, now offers this revolutionary ...
(Date:4/25/2017)... ... April 25, 2017 , ... Buyers and sellers in the thriving multi-billion ... head shops –can’t help but be heartened by the industry’s current surge. But another ... described as “skunk smell.” At last they can simply, safely and effectively end ...
(Date:4/25/2017)... ... 25, 2017 , ... There is no better place in South Florida to ... in the May issue of Consumer Reports focused on heart health. , The ... during and after coronary bypass and aortic valve replacement procedures. , Consumer Reports ...
Breaking Medicine News(10 mins):